Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

10.79
Delayed Data
As of 4:00pm ET
 +0.30 / +2.86%
Today’s Change
7.56
Today|||52-Week Range
14.15
+2.37%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close10.49
Today’s open10.45
Day’s range10.26 - 10.82
Volume665,237
Average volume (3 months)854,177
Market cap$1.1B
Dividend yield9.27%
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+427.50%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratio30.8
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...+0.33+1.45%
SUPNSupernus Pharmaceuti...-0.15-0.67%
EGRXEagle Pharmaceutical...+0.37+0.49%
ALDRAlder Biopharmaceuti...-0.15-0.69%
Data as of 4:00pm ET, 12/08/2016

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)$0.21
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs